SurModics Net Debt vs Net Working Capital Analysis

SRDX Stock

USD 35.27 0.38 1.09%

SurModics financial indicator trend analysis is much more than just breaking down SurModics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether SurModics is a good investment. Please check the relationship between SurModics Net Debt and its Net Working Capital accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SurModics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy SurModics Stock please use our How to Invest in SurModics guide.

Net Debt vs Net Working Capital

Net Debt vs Net Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of SurModics Net Debt account and Net Working Capital. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between SurModics' Net Debt and Net Working Capital is -0.29. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of SurModics, assuming nothing else is changed. The correlation between historical values of SurModics' Net Debt and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of SurModics are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Net Debt i.e., SurModics' Net Debt and Net Working Capital go up and down completely randomly.

Correlation Coefficient

-0.29

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Net Working Capital

Most indicators from SurModics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into SurModics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SurModics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy SurModics Stock please use our How to Invest in SurModics guide.At this time, SurModics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 1.3 M in 2024, despite the fact that Discontinued Operations is likely to grow to (150.5 K).

	2021	2022	2023	2024 (projected)
Gross Profit	29M	61.0M	70.2M	47.1M
Total Revenue	100.0M	132.6M	152.5M	160.1M

Gross Profit Total Revenue

SurModics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock Total Equity	Short Term Investments	Common Stock	Other Liab	Other Assets
Total Assets		0.69	0.8	0.93	0.94	0.05	0.76	0.82	0.45	0.93	-0.52	0.59	0.8	-0.27	0.74	0.64	0.06	0.23	0.82	0.73	0.89	0.58	0.19	0.59	0.89	0.57
Other Current Liab	0.69		0.91	0.54	0.76	0.2	0.31	0.66	0.33	0.65	-0.18	0.35	0.73	-0.19	0.69	0.63	0.14	0.39	0.83	0.68	0.61	0.26	0.16	0.27	0.63	0.4
Total Current Liabilities	0.8	0.91		0.64	0.87	0.31	0.4	0.76	0.25	0.83	-0.21	0.28	0.8	-0.29	0.75	0.68	0.08	0.44	0.91	0.8	0.61	0.29	0.15	0.29	0.83	0.38
Total Stockholder Equity	0.93	0.54	0.64		0.89	-0.17	0.9	0.65	0.53	0.85	-0.7	0.67	0.72	-0.15	0.62	0.53	0.07	0.0	0.67	0.6	0.85	0.73	0.22	0.74	0.75	0.76
Property Plant And Equipment Net	0.94	0.76	0.87	0.89		0.05	0.73	0.77	0.35	0.87	-0.5	0.6	0.8	-0.3	0.71	0.57	0.01	0.18	0.83	0.67	0.84	0.52	0.37	0.52	0.9	0.61
Net Debt	0.05	0.2	0.31	-0.17	0.05		-0.43	0.38	-0.53	0.32	0.5	-0.63	0.23	0.14	0.36	0.4	0.31	0.69	0.36	0.41	-0.29	-0.3	-0.1	-0.29	0.21	-0.57
Retained Earnings	0.76	0.31	0.4	0.9	0.73	-0.43		0.45	0.41	0.63	-0.86	0.75	0.4	-0.12	0.25	0.16	-0.09	-0.41	0.34	0.25	0.77	0.83	0.37	0.83	0.59	0.81
Accounts Payable	0.82	0.66	0.76	0.65	0.77	0.38	0.45		0.2	0.8	-0.36	0.31	0.71	-0.2	0.71	0.7	0.2	0.41	0.78	0.71	0.68	0.41	0.13	0.43	0.77	0.09
Cash	0.45	0.33	0.25	0.53	0.35	-0.53	0.41	0.2		0.24	-0.44	0.57	0.54	-0.34	0.51	0.53	-0.14	0.06	0.43	0.47	0.61	0.27	-0.33	0.28	0.15	0.49
Non Current Assets Total	0.93	0.65	0.83	0.85	0.87	0.32	0.63	0.8	0.24		-0.38	0.28	0.79	-0.13	0.74	0.68	0.17	0.36	0.83	0.81	0.65	0.53	0.09	0.54	0.87	0.45
Non Currrent Assets Other	-0.52	-0.18	-0.21	-0.7	-0.5	0.5	-0.86	-0.36	-0.44	-0.38		-0.74	-0.2	0.01	-0.16	-0.09	0.04	0.55	-0.19	-0.08	-0.58	-0.81	-0.37	-0.81	-0.33	-0.64
Cash And Short Term Investments	0.59	0.35	0.28	0.67	0.6	-0.63	0.75	0.31	0.57	0.28	-0.74		0.26	-0.35	0.27	0.06	-0.23	-0.42	0.29	0.04	0.84	0.49	0.55	0.49	0.45	0.67
Net Receivables	0.8	0.73	0.8	0.72	0.8	0.23	0.4	0.71	0.54	0.79	-0.2	0.26		-0.28	0.88	0.89	0.1	0.58	0.91	0.92	0.65	0.27	-0.17	0.28	0.68	0.37
Common Stock Shares Outstanding	-0.27	-0.19	-0.29	-0.15	-0.3	0.14	-0.12	-0.2	-0.34	-0.13	0.01	-0.35	-0.28		-0.36	-0.21	0.81	0.0	-0.36	-0.24	-0.39	0.36	-0.08	0.35	-0.41	0.04
Non Current Liabilities Total	0.74	0.69	0.75	0.62	0.71	0.36	0.25	0.71	0.51	0.74	-0.16	0.27	0.88	-0.36		0.92	0.05	0.62	0.96	0.9	0.59	0.1	-0.08	0.12	0.66	0.16
Inventory	0.64	0.63	0.68	0.53	0.57	0.4	0.16	0.7	0.53	0.68	-0.09	0.06	0.89	-0.21	0.92		0.18	0.71	0.88	0.95	0.47	0.16	-0.36	0.17	0.47	0.07
Other Current Assets	0.06	0.14	0.08	0.07	0.01	0.31	-0.09	0.2	-0.14	0.17	0.04	-0.23	0.1	0.81	0.05	0.18		0.39	0.07	0.16	-0.08	0.29	-0.12	0.29	-0.07	0.03
Other Stockholder Equity	0.23	0.39	0.44	0.0	0.18	0.69	-0.41	0.41	0.06	0.36	0.55	-0.42	0.58	0.0	0.62	0.71	0.39		0.59	0.7	0.03	-0.32	-0.47	-0.3	0.26	-0.35
Total Liab	0.82	0.83	0.91	0.67	0.83	0.36	0.34	0.78	0.43	0.83	-0.19	0.29	0.91	-0.36	0.96	0.88	0.07	0.59		0.92	0.64	0.19	0.02	0.2	0.78	0.27
Property Plant And Equipment Gross	0.73	0.68	0.8	0.6	0.67	0.41	0.25	0.71	0.47	0.81	-0.08	0.04	0.92	-0.24	0.9	0.95	0.16	0.7	0.92		0.49	0.19	-0.34	0.2	0.64	0.19
Total Current Assets	0.89	0.61	0.61	0.85	0.84	-0.29	0.77	0.68	0.61	0.65	-0.58	0.84	0.65	-0.39	0.59	0.47	-0.08	0.03	0.64	0.49		0.52	0.28	0.54	0.73	0.6
Common Stock Total Equity	0.58	0.26	0.29	0.73	0.52	-0.3	0.83	0.41	0.27	0.53	-0.81	0.49	0.27	0.36	0.1	0.16	0.29	-0.32	0.19	0.19	0.52		0.19	1.0	0.33	0.68
Short Term Investments	0.19	0.16	0.15	0.22	0.37	-0.1	0.37	0.13	-0.33	0.09	-0.37	0.55	-0.17	-0.08	-0.08	-0.36	-0.12	-0.47	0.02	-0.34	0.28	0.19		0.18	0.35	0.27
Common Stock	0.59	0.27	0.29	0.74	0.52	-0.29	0.83	0.43	0.28	0.54	-0.81	0.49	0.28	0.35	0.12	0.17	0.29	-0.3	0.2	0.2	0.54	1.0	0.18		0.34	0.67
Other Liab	0.89	0.63	0.83	0.75	0.9	0.21	0.59	0.77	0.15	0.87	-0.33	0.45	0.68	-0.41	0.66	0.47	-0.07	0.26	0.78	0.64	0.73	0.33	0.35	0.34		0.38
Other Assets	0.57	0.4	0.38	0.76	0.61	-0.57	0.81	0.09	0.49	0.45	-0.64	0.67	0.37	0.04	0.16	0.07	0.03	-0.35	0.27	0.19	0.6	0.68	0.27	0.67	0.38

Click cells to compare fundamentals

SurModics Account Relationship Matchups

SurModics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	168.8M	194.6M	158.4M	185.7M	213.6M	140.7M
Other Current Liab	11.7M	13.4M	14.8M	15.7M	18.1M	19.0M
Total Current Liabilities	18.9M	29.8M	32.1M	24.0M	27.5M	28.9M
Total Stockholder Equity	131.1M	140.1M	108.4M	119.9M	137.9M	116.0M
Property Plant And Equipment Net	30.1M	30.1M	27.1M	26.0M	29.9M	26.5M
Net Debt	(30.3M)	(21.2M)	(5.2M)	(12.0M)	(10.8M)	(11.4M)
Retained Earnings	111.8M	116.1M	88.8M	87.3M	100.3M	71.6M
Accounts Payable	1.5M	1.8M	3.1M	3.0M	3.4M	1.9M
Cash	30.8M	31.2M	19.0M	41.4M	47.6M	50.0M
Non Current Assets Total	82.2M	124.3M	100.8M	99.0M	113.9M	88.0M
Non Currrent Assets Other	4.3M	3.7M	4.8M	3.9M	3.5M	3.3M
Cash And Short Term Investments	61.1M	38.9M	19.0M	45.4M	52.2M	35.1M
Net Receivables	13.8M	16.3M	17.6M	18.6M	21.4M	22.5M
Common Stock Shares Outstanding	13.8M	14.0M	13.9M	14.0M	12.6M	13.7M
Liabilities And Stockholders Equity	168.8M	194.6M	158.4M	185.7M	213.6M	140.7M
Non Current Liabilities Total	18.8M	24.7M	17.9M	41.9M	48.1M	50.6M
Inventory	6.0M	6.8M	11.8M	14.8M	17.1M	17.9M
Other Current Assets	5.8M	8.4M	9.2M	7.9M	9.0M	8.0M
Other Stockholder Equity	15.4M	21.6M	28.8M	36.7M	33.0M	31.8M
Total Liab	37.7M	54.5M	50.0M	65.8M	75.7M	79.5M
Property Plant And Equipment Gross	32.6M	80.2M	82.1M	85.5M	98.3M	103.2M
Total Current Assets	86.6M	70.3M	57.6M	86.7M	99.7M	52.8M
Accumulated Other Comprehensive Income	3.2M	1.7M	(9.9M)	(4.8M)	(4.3M)	(4.1M)
Common Stock Total Equity	670K	675K	684K	701K	630.9K	615.8K
Short Term Investments	24.9M	30.3M	7.7M	3.9M	4.5M	4.3M
Other Liab	17.1M	15.5M	24.7M	17.9M	20.6M	10.9M
Other Assets	7.8M	9.1M	9.6M	4.8M	5.5M	6.7M
Property Plant Equipment	29.7M	30.1M	30.1M	27.1M	31.2M	28.0M
Current Deferred Revenue	5.2M	4.6M	4.2M	4.4M	5.0M	5.3M
Intangible Assets	13.3M	37.1M	28.1M	26.2M	30.1M	17.1M
Short Term Debt	2.1M	436K	10M	872K	784.8K	745.6K
Good Will	27.2M	45.6M	40.7M	42.9M	49.4M	51.9M
Retained Earnings Total Equity	110.7M	111.8M	116.1M	88.8M	102.1M	87.6M
Capital Surpluse	10.7M	15.4M	21.6M	28.8M	25.9M	14.1M
Deferred Long Term Liab	11.6M	10.8M	13.0M	7.1M	8.2M	5.4M
Non Current Liabilities Other	8.0M	14.4M	12.8M	10.1M	11.6M	9.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
MSFT	Microsoft
BAC	Bank of America

When determining whether SurModics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SurModics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surmodics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surmodics Stock:

How To Invest In SurModics

Details

Is SurModics Stock a good investment?

Details

What is SurModics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SurModics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy SurModics Stock please use our How to Invest in SurModics guide.

Note that the SurModics information on this page should be used as a complementary analysis to other SurModics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for SurModics Stock analysis

When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.

	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Transaction History View history of all your transactions and understand their impact on performance
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Stocks Directory Find actively traded stocks across global markets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

Is SurModics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SurModics. If investors know SurModics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SurModics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

4.358

Earnings Share

0.96

Revenue Per Share

10.147

Quarterly Revenue Growth

0.175

Return On Assets

0.0661

The market value of SurModics is measured differently than its book value, which is the value of SurModics that is recorded on the company's balance sheet. Investors also form their own opinion of SurModics' value that differs from its market value or its book value, called intrinsic value, which is SurModics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SurModics' market value can be influenced by many factors that don't directly affect SurModics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between SurModics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SurModics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SurModics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

SurModics Net Debt vs Net Working Capital Analysis

Net Debt vs Net Working Capital

Net Debt vs Net Working Capital Correlation Analysis

Correlation Coefficient

Net Debt

Net Working Capital

SurModics fundamental ratios Correlations

SurModics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

SurModics fundamental ratios Accounts

Also Currently Popular

Complementary Tools for SurModics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.96	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.95	Inventory
Property Plant And Equipment Net	+ 0.94	Total Assets
Total Stockholder Equity	+ 0.93	Total Assets
Non Current Assets Total	+ 0.93	Total Assets

Non Currrent Assets Other	- 0.86	Retained Earnings
Common Stock	- 0.81	Non Currrent Assets Other
Common Stock Total Equity	- 0.81	Non Currrent Assets Other
Cash And Short Term Investments	- 0.74	Non Currrent Assets Other
Non Currrent Assets Other	- 0.7	Total Stockholder Equity
Other Assets	- 0.64	Non Currrent Assets Other